Febrile Neutropenic Patients in Hematological Malignancies

Neutropenia, characterized by an abnormally low count of neutrophils, poses a critical challenge in patients with hematological malignancies, significantly impacting their treatment outcomes and healthcare resources. This chapter delves into the multifaceted aspects of neutropenia, encompassing its epidemiology, risk factors, clinical presentations, and management strategies. It aims to furnish healthcare professionals with a detailed comprehension of neutropenia, accentuating evidence-based diagnostic and therapeutic protocols and introducing practical tools for clinical decision-making. Through an integrative approach that combines the latest guidelines and research findings with clinical utility, this chapter endeavors to enhance the management of neutropenic patients in hematology and critical care settings, ultimately aspiring to improve patient outcomes and mitigate healthcare costs.